FDA Panel Rejects Steroid-Sparing Claim For Remicade In Pediatric Ulcerative Colitis

Extrapolation from adult data does not work in this case and there is insufficient supporting pediatric data, the Gastrointestinal Drugs Advisory Committee concluded July 21.

More from Archive

More from Pink Sheet